Vertex Pharmaceuticals financial statements
버텍스 파머슈티컬NASDAQ:VRTX · Nasdaq · Healthcare$504.73-0.40%
2026-10-02 closeVertex Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $11.02B. 2024 operating profit was −$233M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy